iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.7914
+0.0181 (2.34%)
At close: May 12, 2025, 4:00 PM
0.8000
+0.0086 (1.09%)
After-hours: May 12, 2025, 7:49 PM EDT

iBio, Inc. Market Cap

iBio, Inc. has a market cap or net worth of $13.07 million as of May 12, 2025. Its market cap has increased by 98.08% in one year.

Market Cap
13.07M
Enterprise Value
11.92M
1-Year Change
98.08%
Ranking
Category
Stock Price
$0.79

Market Cap Chart

Since November 16, 2009, iBio, Inc.'s market cap has decreased from $27.70M to $13.07M, a decrease of -52.80%. That is a compound annual growth rate of -4.73%.

History

DateMarket Cap% Change
May 9, 202512.80M-42.86%
Dec 31, 202422.40M1,078.95%
Dec 29, 20231.90M-52.50%
Dec 30, 20224.00M-96.66%
Dec 31, 2021119.70M-37.40%
Dec 31, 2020191.20M2,320.25%
Dec 31, 20197.90M-43.57%
Dec 31, 201814.00M-14.63%
Dec 29, 201716.40M-53.41%
Dec 30, 201635.20M-18.71%
Dec 31, 201543.30M-12.17%
Dec 31, 201449.30M128.24%
Dec 31, 201321.60M-27.03%
Dec 31, 201229.60M10.04%
Dec 30, 201126.90M-73.23%
Dec 31, 2010100.50M298.81%
Dec 31, 200925.20M-9.03%
View and export this data all the way back to 2009. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 658.02B
Johnson & Johnson 369.91B
UnitedHealth Group 344.58B
AbbVie 332.26B
Novo Nordisk 297.79B
Abbott Laboratories 231.36B
Novartis AG 214.71B
AstraZeneca 211.14B
Market Cap Rankings